Why Did Diamedica Stock Soar 7.13%? Insider Buying Boosts Sentiment

On July 28, 2025, Diamedica's stock surged by 7.13% in pre-market trading, indicating a strong bullish sentiment among investors.

Jan Stahlberg, a significant investor, acquired 1,542,857 shares of Diamedica Therapeutics, Inc. This substantial purchase suggests confidence in the company's future prospects and may have contributed to the recent stock price increase.

Additionally, TomEnterprise Private AB, another major shareholder, invested $10 million in Diamedica Therapeutics. This investment further underscores the positive outlook for the company and its potential for growth.

Despite these positive developments, analysts predict that Diamedica Therapeutics' earnings will decrease in the coming year, from ($0.59) to ($0.80) per share. This forecast may temper some of the enthusiasm surrounding the stock, but the recent insider buying activity provides a counterbalance, suggesting that key stakeholders remain optimistic about the company's long-term prospects.